Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details Narrative)

v3.10.0.1
Stockholders' Equity (Details Narrative) - USD ($)
 2 Months Ended 6 Months Ended
May 25, 2018
Mar. 19, 2018
Oct. 04, 2017
Jun. 29, 2018
Jun. 30, 2018
Dec. 31, 2017
Number of shares acquired in exchange for common stock     31,745,242   2,090,301  
Precentage of issued and outstanding common stock diluted basis     90.00%      
Common stock issued         38,674,265 35,272,626
Common stock shares outstanding         38,674,265 35,272,626
Recognization of license intangible asset         8,000,000  
Additional Paid-In Capital [Member]            
Recognization of license intangible asset         8,000,000  
CoNCERT Pharmaceuticals, Inc [Member]            
Common stock and a warrant purchase price per share   $ 3.83        
Option exercised in exchange for common stock   $ 8,000,000        
Number of shares acquired in exchange for common stock   2,090,301        
Percentage of common stock holdings   6.58%        
Precentage of issued and outstanding common stock diluted basis   5.93%        
Common stock issued   35,272,626        
Common stock shares outstanding   35,272,626        
Controlling interest, description   Promet’s controlling interest was reduced from 90% to 84%.        
CoNCERT Pharmaceuticals, Inc [Member] | Additional Paid-In Capital [Member]            
Recognization of license intangible asset         8,000,000  
2018 Private Placement Transactions [Member]            
Number of units sold       1,402,442    
Purchase price per unit       $ 2.27    
Gross proceeds from unit sold       $ 3,200,000    
Common stock and a warrant purchase price per share       $ 2.724    
Amount paid to placement agent       $ 167,526    
Issued placement agent warrants to purchase shares       84,146    
Warrants term       3 years    
Notes receivable       $ 107,490    
PoC Capital, LLC [Member]            
Number of units sold 792,952          
Purchase price per unit $ 2.724          
Common stock and a warrant purchase price per share $ 2.724          
Amount paid to placement agent $ 108,000          
Issued placement agent warrants to purchase shares 47,578          
Warrants term 3 years          
Amount financed under agreement $ 1,800,000          
Pledge Agreement with PoC [Member]            
Number of units sold 396,476          
Purchase price per unit $ 2.27          
Gross proceeds from unit sold $ 20,000,000          
Common stock and a warrant purchase price per share $ 0.01          
Amount paid to placement agent $ 720,000